| UniProt ID | RL22L_HUMAN | |
|---|---|---|
| UniProt AC | Q6P5R6 | |
| Protein Name | 60S ribosomal protein L22-like 1 | |
| Gene Name | RPL22L1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 122 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MAPQKDRKPKRSTWRFNLDLTHPVEDGIFDSGNFEQFLREKVKVNGKTGNLGNVVHIERFKNKITVVSEKQFSKRYLKYLTKKYLKKNNLRDWLRVVASDKETYELRYFQISQDEDESESED | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 47 | Ubiquitination | EKVKVNGKTGNLGNV HHHEECCCCCCCCCE | 48.32 | 21906983 | |
| 65 | Phosphorylation | ERFKNKITVVSEKQF EEECCCEEEEEHHHH | 19.23 | 21406692 | |
| 68 | Phosphorylation | KNKITVVSEKQFSKR CCCEEEEEHHHHHHH | 34.44 | 21406692 | |
| 70 | Acetylation | KITVVSEKQFSKRYL CEEEEEHHHHHHHHH | 49.49 | 23236377 | |
| 70 | Ubiquitination | KITVVSEKQFSKRYL CEEEEEHHHHHHHHH | 49.49 | - | |
| 74 | Acetylation | VSEKQFSKRYLKYLT EEHHHHHHHHHHHHH | 46.48 | 7976705 | |
| 78 | Acetylation | QFSKRYLKYLTKKYL HHHHHHHHHHHHHHH | 29.31 | 24588809 | |
| 78 | Ubiquitination | QFSKRYLKYLTKKYL HHHHHHHHHHHHHHH | 29.31 | 21890473 | |
| 99 | Phosphorylation | DWLRVVASDKETYEL HHHHHHHCCCCEEEE | 37.29 | 26074081 | |
| 101 | Acetylation | LRVVASDKETYELRY HHHHHCCCCEEEEEE | 49.84 | 26051181 | |
| 101 | Ubiquitination | LRVVASDKETYELRY HHHHHCCCCEEEEEE | 49.84 | 2190698 | |
| 103 | Phosphorylation | VVASDKETYELRYFQ HHHCCCCEEEEEEEE | 28.21 | 26074081 | |
| 104 | Phosphorylation | VASDKETYELRYFQI HHCCCCEEEEEEEEE | 17.66 | 28152594 | |
| 108 | Phosphorylation | KETYELRYFQISQDE CCEEEEEEEEEECCC | 16.68 | 23403867 | |
| 112 | Phosphorylation | ELRYFQISQDEDESE EEEEEEEECCCCCCC | 22.31 | 28176443 | |
| 118 | Phosphorylation | ISQDEDESESED--- EECCCCCCCCCC--- | 59.76 | 25159151 | |
| 120 | Phosphorylation | QDEDESESED----- CCCCCCCCCC----- | 57.24 | 30266825 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RL22L_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL22L_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL22L_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FP100_HUMAN | C17orf70 | physical | 26186194 | |
| T3HPD_HUMAN | L3HYPDH | physical | 26186194 | |
| VMAC_HUMAN | VMAC | physical | 26186194 | |
| MDM2_HUMAN | MDM2 | physical | 26186194 | |
| CC85B_HUMAN | CCDC85B | physical | 26186194 | |
| VMAC_HUMAN | VMAC | physical | 28514442 | |
| FP100_HUMAN | C17orf70 | physical | 28514442 | |
| CC85B_HUMAN | CCDC85B | physical | 28514442 | |
| T3HPD_HUMAN | L3HYPDH | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118, AND MASSSPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118 AND SER-120, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118 AND SER-120, ANDMASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120, AND MASSSPECTROMETRY. | |